Valeant (VRX) PT Cut to $33 at RBC Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. JBHT
3. CRWV
4. SCHW
5. GPRK
6. TFC
7. NEST:IN
8. AA
9. TECHM:IN
10. NVDA

Go back to Valeant (VRX) PT Cut to $33 at RBC Capital

Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results

June 7, 2016 6:00 AM EDT

LAVAL, Quebec, June 7, 2016 /PRNewswire/ --

Total Revenues of $2.4 billion, an increase of  9% versus the first quarter of 2015 (restated) GAAP EPS  ($1.08); Adjusted EPS (non-GAAP)  $1.27 GAAP Cash Flow from Operations was $558 million, an increase of 14% versus the first quarter of 2015 (restated) Updated Full Year 2016 Guidance: Total Revenue updated to $9.9 - $10.1 billion from $11.0 - $11.2 billion  Adjusted EPS (non-GAAP) updated to $6.60 - $7.00 from $8.50 - $9.50  Adjusted EBITDA (non-GAAP) is updated to $4.80 - $4.95 billion from $5.60 - $5.80 billion

Valeant Pharmaceuticals International,... More